Sanofi (SNY) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Sanofi's Net Income Attributable to Noncontrolling Interests came in at $55.22 million for Q3 2026, up 687.3% from $7.01 million a year earlier and up 39.7% from the prior quarter.
Sanofi (SNY) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Sanofi reported Net Income Attributable to Noncontrolling Interests of $109.91 million, up 136.6% year-over-year; for FY2025, it was $42.93 million, down 31.6% from FY2024.
- Net Income Attributable to Noncontrolling Interests carries a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- Going back by year, Net Income Attributable to Noncontrolling Interests was $62.78 million in FY2024 (+61.2%), $38.94 million in FY2023 (-67.3%), $119.1 million in FY2022 (+79.7%) and $66.27 million in FY2021 (+61.2%).
- The Q3 2026 figure represents the highest quarterly Net Income Attributable to Noncontrolling Interests since Q4 2022.
- Year-over-year, Net Income Attributable to Noncontrolling Interests increased in four of the last seven quarters, with growth averaging 191.3%.
- The fastest year-over-year change in Net Income Attributable to Noncontrolling Interests over five years came in Q2 2026 (growth of 772.8%), and the weakest in Q3 2022 (a decline of 90.1%).
- Business Quant data shows SNY's Net Income Attributable to Noncontrolling Interests at $39.52 million (Q2 2026), $7.02 million (Q1 2026) and $8.15 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Sanofi | 59.05 Bn | 29.25 Bn | 33.35 Bn | 55.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55.22 Mn |
| Jun 30, 2026 | 39.52 Mn |
| Mar 31, 2026 | 7.02 Mn |
| Dec 31, 2025 | 8.15 Mn |
| Sep 30, 2025 | 7.01 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 22.09 Mn |
| Dec 31, 2024 | 12.82 Mn |
| Sep 30, 2024 | 31.85 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 14.12 Mn |
| Dec 31, 2023 | -3.23 Mn |
| Sep 30, 2023 | 14.15 Mn |
| Jun 30, 2023 | 13.07 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 58.15 Mn |
| Sep 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 64.02 Mn |
| Mar 31, 2022 | -7.86 Mn |
| Dec 31, 2021 | 11.44 Mn |
Sanofi Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();